ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
9.77
+0.07 (0.72%)
Jun 9, 2026, 4:00 PM EDT - Market closed
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $88.39 million as of June 10, 2026. Its market cap has increased by 50.00% in one year.
Market Cap
88.39M
Enterprise Value
94.35M
1-Year Change
50.00%
Ranking
Category
Stock Price
$9.77
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $88.39M, an increase of 4,337.11%. That is a compound annual growth rate of 11.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 88.39M | 58.88% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 88.80M |
| Fortress Biotech | 88.03M |
| Rein Therapeutics | 87.75M |
| Inovio Pharmaceuticals | 87.67M |
| PolyPid | 86.28M |
| OKYO Pharma | 85.02M |
| Atara Biotherapeutics | 84.44M |
| Rallybio | 84.37M |